520 related articles for article (PubMed ID: 33782413)
1. The relative deficit of GDF15 in adolescent girls with PCOS can be changed into an abundance that reduces liver fat.
de Zegher F; Díaz M; Villarroya J; Cairó M; López-Bermejo A; Villarroya F; Ibáñez L
Sci Rep; 2021 Mar; 11(1):7018. PubMed ID: 33782413
[TBL] [Abstract][Full Text] [Related]
2. Organokines and liver enzymes in adolescent girls with polycystic ovary syndrome during randomized treatments.
Garcia-Beltran C; Peyrou M; Navarro-Gascon A; López-Bermejo A; de Zegher F; Villarroya F; Ibáñez L
Front Endocrinol (Lausanne); 2024; 15():1325230. PubMed ID: 38818508
[TBL] [Abstract][Full Text] [Related]
3. Reduced circulating levels of chemokine CXCL14 in adolescent girls with polycystic ovary syndrome: normalization after insulin sensitization.
García-Beltran C; Cereijo R; Quesada-López T; Malpique R; López-Bermejo A; de Zegher F; Ibáñez L; Villarroya F
BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32107266
[TBL] [Abstract][Full Text] [Related]
4. Normalizing Ovulation Rate by Preferential Reduction of Hepato-Visceral Fat in Adolescent Girls With Polycystic Ovary Syndrome.
Ibáñez L; Del Río L; Díaz M; Sebastiani G; Pozo ÓJ; López-Bermejo A; de Zegher F
J Adolesc Health; 2017 Oct; 61(4):446-453. PubMed ID: 28712591
[TBL] [Abstract][Full Text] [Related]
5. Towards a circulating marker of hepato-visceral fat excess: S100A4 in adolescent girls with polycystic ovary syndrome - Evidence from randomized clinical trials.
Malpique R; Sánchez-Infantes D; Garcia-Beltran C; Taxerås SD; López-Bermejo A; de Zegher F; Ibáñez L
Pediatr Obes; 2019 May; 14(5):e12500. PubMed ID: 30653851
[TBL] [Abstract][Full Text] [Related]
6. Effects of half-dose spiomet treatment in girls with early puberty and accelerated bone maturation: a multicenter, randomized, placebo-controlled study protocol.
Bassols J; de Zegher F; Diaz M; Carreras-Badosa G; Garcia-Beltran C; Puerto-Carranza E; Oliver-Vila C; Casano P; Franco CA; Malpique R; López-Bermejo A; Ibáñez L
Trials; 2023 Jan; 24(1):56. PubMed ID: 36694227
[TBL] [Abstract][Full Text] [Related]
7. Low Circulating Levels of miR-451a in Girls with Polycystic Ovary Syndrome: Different Effects of Randomized Treatments.
Díaz M; Bassols J; López-Bermejo A; de Zegher F; Ibáñez L
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31730174
[TBL] [Abstract][Full Text] [Related]
8. SPIOMET4HEALTH-efficacy, tolerability and safety of lifestyle intervention plus a fixed dose combination of spironolactone, pioglitazone and metformin (SPIOMET) for adolescent girls and young women with polycystic ovary syndrome: study protocol for a multicentre, randomised, double-blind, placebo-controlled, four-arm, parallel-group, phase II clinical trial.
Garcia-Beltran C; Malpique R; Andersen MS; Bas F; Bassols J; Darendeliler F; Díaz M; Dieris B; Fanelli F; Fröhlich-Reiterer E; Gambineri A; Glintborg D; López-Bermejo A; Mann C; Marin S; Obermayer-Pietsch B; Ødegård R; Ravn P; Reinehr T; Renzulli M; Salvador C; Singer V; Vanky E; Torres JV; Yildiz M; de Zegher F; Ibáñez L
Trials; 2023 Sep; 24(1):589. PubMed ID: 37715279
[TBL] [Abstract][Full Text] [Related]
9. Circulating follistatin concentrations in adolescent PCOS: Divergent effects of randomized treatments.
Díaz M; de Zegher F; Ibáñez L
Front Endocrinol (Lausanne); 2023; 14():1125569. PubMed ID: 36843579
[TBL] [Abstract][Full Text] [Related]
10. Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.
Ibáñez L; de Zegher F
J Clin Endocrinol Metab; 2004 Apr; 89(4):1592-7. PubMed ID: 15070917
[TBL] [Abstract][Full Text] [Related]
11. Raised Thyroid-Stimulating Hormone in Girls with Polycystic Ovary Syndrome: Effects of Randomized Interventions.
Garcia-Beltran C; Bassols J; Carreras-Badosa G; López Bermejo A; Ibáñez L; de Zegher F
Horm Res Paediatr; 2023; 96(5):458-464. PubMed ID: 36649684
[TBL] [Abstract][Full Text] [Related]
12. Toward a Treatment Normalizing Ovulation Rate in Adolescent Girls With Polycystic Ovary Syndrome.
Ibáñez L; Díaz M; García-Beltrán C; Malpique R; Garde E; López-Bermejo A; de Zegher F
J Endocr Soc; 2020 May; 4(5):bvaa032. PubMed ID: 32342022
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota in adolescent girls with polycystic ovary syndrome: Effects of randomized treatments.
Garcia-Beltran C; Malpique R; Carbonetto B; González-Torres P; Henares D; Brotons P; Muñoz-Almagro C; López-Bermejo A; de Zegher F; Ibáñez L
Pediatr Obes; 2021 Apr; 16(4):e12734. PubMed ID: 32989872
[TBL] [Abstract][Full Text] [Related]
14. Adolescent polycystic ovary syndrome without obesity: HOTAIR rs1443512 genotype relates to fat mass and to the redistribution of fat mass on low-dose pioglitazone.
de Zegher F; Díaz M; Ibáñez L
J Endocrinol Invest; 2024 Apr; 47(4):1037-1043. PubMed ID: 37805962
[TBL] [Abstract][Full Text] [Related]
15. Polycystic ovary syndrome in adolescent girls.
Ibáñez L; de Zegher F
Pediatr Obes; 2020 Feb; 15(2):e12586. PubMed ID: 31663293
[TBL] [Abstract][Full Text] [Related]
16. Circulating GDF15 concentrations in girls with low birth weight: effects of prolonged metformin treatment.
Díaz M; Carreras-Badosa G; Villarroya J; Gavaldà-Navarro A; Bassols J; de Zegher F; López-Bermejo A; Villarroya F; Ibáñez L
Pediatr Res; 2023 Mar; 93(4):964-968. PubMed ID: 35817957
[TBL] [Abstract][Full Text] [Related]
17. Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.
Ganie MA; Khurana ML; Nisar S; Shah PA; Shah ZA; Kulshrestha B; Gupta N; Zargar MA; Wani TA; Mudasir S; Mir FA; Taing S
J Clin Endocrinol Metab; 2013 Sep; 98(9):3599-607. PubMed ID: 23846820
[TBL] [Abstract][Full Text] [Related]
18. Menstrual cyclicity post OC withdrawal in PCOS: Use of non-hormonal options.
Kulshreshtha B; Arora A; Pahuja I; Sharma N; Pant S
J Obstet Gynaecol; 2016 Aug; 36(6):833-838. PubMed ID: 26982394
[TBL] [Abstract][Full Text] [Related]
19. Low-Dose Spironolactone-Pioglitazone-Metformin Normalizes Circulating Fetuin-A Concentrations in Adolescent Girls with Polycystic Ovary Syndrome.
Díaz M; Gallego-Escuredo JM; López-Bermejo A; de Zegher F; Villarroya F; Ibáñez L
Int J Endocrinol; 2018; 2018():4192940. PubMed ID: 30123261
[TBL] [Abstract][Full Text] [Related]
20. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
